ABIVAX |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.06 EUR | +1.74% |
|
-5.13% | +43.18% |
| 04-29 | Abivax: share price rises as two analysts express optimism | CF |
| 04-29 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 953M | - | |||||
| 47.86B | - | |||||
| 41.42B | ||||||
| 40.66B | ||||||
| 28.92B | ||||||
| 25.55B |
- Stock Market
- Equities
- ABVX Stock
- Charts Abivax
- Sector Chart
